eczema

rocket launch satellite space fly blast off
Biotech

Amgen ignites Rocket program with wins in phase 3 eczema trials

The data provide more evidence rocatinlimab improves outcomes, but questions about the antibody's positioning versus Dupixent remain unanswered.
Nick Paul Taylor Mar 10, 2025 5:48am
Person throwing piece of paper into full waste bin

Anaptys scraps atopic dermatitis asset after ph. 2 fail

Dec 11, 2024 11:02am
target reach ladder climb meet win beat competition

Amgen reports first phase 3 win for $400M eczema drug

Sep 25, 2024 5:50am
Deal terminate tear up end deal scrap

Connect uncouples from Pfizer by scrapping eczema pact

Apr 17, 2024 6:38am
eczema atopic dermatitis Black African American patient skin of color

Lilly's lebrikizumab clears eczema in people with skin of color

Mar 11, 2024 9:24am
game connect

Connecting the dots: Asthma asset aces phase 2b trial

Dec 12, 2023 11:00am